Search
for
Sort by
Research 31–60 of 348
- GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
- Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications
- Glucagon-Like Peptide-1 Receptor Agonists and Hair Loss: Current Evidence and Potential Mechanisms
- Mitigating GLP-1–Related Dermatologic Adverse Effects through Methylene Blue’s Antioxidant Action
- Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes
- Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study
- GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling
- Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin
- Nonscarring Alopecia in Adults Treated With GLP ‐1s: A Propensity Score Matched TriNetX Cohort Study
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Abstract 4142154: Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- 74126 GLP-1RA Medications and Alopecia: Evaluating Risk Across Diabetic and Non-Diabetic Populations
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- Treatment of insulin resistance with tirzepatide leading to improvement of hair loss
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- A Review of Metabolic Dysregulation in Lymphocytic Cicatricial Alopecia: Exploring the Connections and Therapeutic Implications
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- EFLÚVIO TELÓGENO ASSOCIADO AO USO DE MEDICAMENTOS EMAGRECEDORES: MECANISMOS FISIOPATOLÓGICOS E EVIDÊNCIAS CLÍNICAS
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Editor's Highlights — September 2024
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Current aspects of polycystic ovary syndrome II: treatment of hyperandrogenism, insulin resistance and infertility
- Maternal obesity and the metabolic syndrome in reproductive health: assessing incretin-based interventions
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review